Approval · Notice of Compliance 12945 · 2012
OZURDEX: Notice of Compliance 12945
Issued January 19, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12945
- Date
- January 19, 2012
- Company
- Allergan IncMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication
- Therapeutic class
- Corticosteroid
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OZURDEX | Not yet assigned | — |
Medicinal ingredients
- DEXAMETHASONE 0.7 MG per IMP